Novel transcript, antisense to ZNF281 (ENSG00000230623)

The gene ENSG00000230623 corresponds to a "novel transcript, antisense to ZNF281," and is annotated as a non-coding RNA gene (specifically a long noncoding RNA, lncRNA), rather than a classical protein target such as a receptor, enzyme, or transporter[1][3][5][7][9][12]. This entity is a long non-coding RNA (lncRNA) identified as a "novel transcript, antisense to ZNF281" (ENSG00000230623). It maps to chromosome 1 (location: 200,333,193-200,479,399, forward strand), and is annotated as a processed transcript, implying it is generated from RNA processing rather than being protein-coding[1][3][5][7]. The transcript is antisense to the ZNF281 gene (zinc finger protein 281), suggesting a possible regulatory interaction with ZNF281 via antisense mechanisms, but this has not been experimentally validated. Its biological function, disease relevance, and therapeutic potential are currently unknown, and it is not established as a canonical drug target[5][9][10][15]. In summary, ENSG00000230623 represents a novel, poorly characterized lncRNA with unknown biological and clinical significance, and does not meet criteria for current therapeutic targets.

Other names

AC104461.1

None established, as no drugs act on this transcript.